Hypertriglyceridemia (HTG) is a feature of numerous metabolic disorders including dyslipidemias, metabolic syndrome, and diabetes mellitus type 2 and can increase the risk of premature coronary artery disease. HTG may also be due to genetic factors (called primary HTG) and particularly the severe/extreme HTG (SEHTG), which is a usually rare genetic disorder. Even rarer are secondary cases of SEHTG caused by autoimmune disease. This review considers the causes of SEHTG, and their management including treatment with low density lipoprotein apheresis and analyzes the original findings.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279422 | PMC |
| http://dx.doi.org/10.1155/2014/109263 | DOI Listing |
Publication Analysis
Top Keywords
original findings
8
severe/extreme hypertriglyceridemia
4
hypertriglyceridemia ldl
4
ldl apheretic
4
apheretic treatment
4
treatment review
4
review literature
4
literature original
4
findings hypertriglyceridemia
4
htg
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!